第三代VNCa双能CT的值,用于区分多发性骨髓瘤的扩散性骨髓透与红骨髓
Tiantian Wang1, Biao Zhou1, Kui Zhang2
1Department of Radiology, The Affiliated Tengzhou Hospital of Xuzhou Medical University, Tengzhou, Shandong Province, China.
Medicine
|May 3, 2024
概括
第三代双能CT虚拟非成像有效区分多发性骨髓瘤 (MM) 骨髓透与红骨髓 (RBM). 这种先进的CT技术在区分MM病变与正常或红色骨髓方面表现出高准确性.
科学领域:
- 放射学 放射学是一门学科.
- 医疗成像医学成像
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 的诊断和分期依赖于准确的骨髓评估.
- 从正常的红骨髓 (RBM) 区分分散的MM透可能是具有挑战性的常规成像.
- 第三代双能计算断层扫描 (CT) 提供了先进的骨髓表征能力.
研究的目的:
- 评估虚拟非 (VNCa) 成像使用第三代双能CT在区分MM骨髓透与RBM的疗效.
- 评估VNCa CT在区分MM,RBM和正常黄色骨髓的诊断性能.
主要方法:
- 回溯分析VNCa骨髓成像数据从MM患者,RBM受试者和正常黄色骨髓的对照组.
- 确定了感兴趣的区域 (ROI),并分析了CT值.
- 采用接收器操作特征 (ROC) 曲线分析来确定诊断性能指标,包括曲线下的面积 (AUC),灵敏度和特异性.
主要成果:
- 在MM,RBM和对照组中观察到VNC和CT值的统计学上显著差异 (P < .001).
- VNCa成像显示,高精度区分MM病变与正常骨髓 (AUC>0.99) 和RBM (区分RBM和MM的AUC=0.723).
- 该技术在区分RBM和MM时表现出卓越的性能,具有扩散的骨髓透,严重透的AUC值高达0.80.
结论:
- 第三代双能量CT VNCa骨髓成像是区分MM骨髓透与RBM和正常骨髓的可靠工具.
- 该研究强调了VNCa成像的潜力,以提高MM分期和监测的诊断准确性.
- VNCa CT提供了一种具有高灵敏度和特异性的非侵入性方法,用于在MM中表征骨髓异常.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.8K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
01:22Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K